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ABSTRACT 
 
Adverse drug reaction was one of the well-known causes of morbidity and mortality in both hospital and community 
settings and it is responsible for about five to twenty percentage of hospital admissions. The accomplishment of 
pharmacovigilance is alarmed with the dynamic involvement of medical professionals. To this purpose we studied 
the Pharmacovigilance awareness among the Interns (House-surgeons) posted in a tertiary care teaching hospital. 
This cross sectional study was conducted among interns (House-surgeons) who actively participate in the treatment 
and care of patients at tertiary care teaching hospital for the period of three months during January 2009 to March 
2009.  Ten points questionnaire was designed and validated to know the awareness ADR reporting and 
Pharmacovigilance. A total of 100 Interns participated in the study group. The participants were between 22-28 
years and the experience of these interns was 0-12 months. Overall >90% of the participants were not aware of any 
of these questions. The percentage of correct answer for question 5 vs. 10 was 5-44 vs.90.33 respectively. Our study 
strongly recommends a massive need to create awareness among the Interns to improve the reporting of ADR and 
awareness about Pharmacovigilance. The training sessions must clarify the roles of the various healthcare 
professionals in Pharmacovigilance. 
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Introduction 
 
 
WHO defined Adverse Drug Reaction is any noxious, 
unintended and undesired effect of the drug which occurs 
at doses used in humans for the prophylaxis, diagnosis or 
therapy of a disease or the modification of physiological 
state as per[1]. The ADR was one of the familiar causes of 
morbidity and mortality in both hospital and community 
settings and it is responsible for about five to twenty 
percentage of hospital admissions[2-3]. It is as well an 
financial burden on health care system due to prolonging 
the hospital stay and augment the expenditure of the cure 
[4]. Majority of Interns are not conscious of significance 
of monitoring and reporting of ADR[5]. 
Pharmacovigilance is a important branch of pharmacology 
defined as science and activities related to detection, 
assessment, understanding and prevention of adverse drug 
reactions 
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important branch of pharmacology defined as science and 
activities related to detection, assessment, understanding 
and prevention of adverse drug reactions or any drug 
related problem. The accomplishment of 
Pharmacovigilance is mainly concerned with the active 
involvement of health care professionals. To this purpose 
we studied the Pharmacovigilance awareness among the 
Interns (House-surgeons) posted in a tertiary care teaching 
hospital. 
 
Methods 
 
This cross sectional study was conducted among interns 
(House-surgeons) who actively participate in the treatment 
and care of patients at Katuri Medical College Hospital, 
Chinakondrupadu, Guntur (A.P) for the period of 3 
months between January-March 2009. PG students, senior 
level doctors and nursing staff were excluded from the 
study. Ethical committee has approved the study. A 
Questionnaire of ten points was designed and validated to 
know the knowledge and awareness about ADR and 
Pharmacovigilance. The interns were requested to fill 
the questionnaire and to return within 2 days. 
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Table 1: Difference between adverse drug reaction and adverse event 
 
1.  Difference between  Adverse drug reaction and Adverse event (Right/Wrong) 
2.  What do mean by Serious Adverse Reaction (SAE) (Right/Wrong) 
3.  Whom to report ADR – Locally  (Right/Wrong) 
4.  Definition of Pharmacovigilance  (Right/Wrong) 
5.  Why ADR has to be reported to Pharmacovigilance Center   (Right/Wrong) 
6.   Pharmacovigilance reporting is Compulsory  (Right/Wrong) 
7.  DCGI–  expand the abbreviation (Right/Wrong) 
8.  CDSCO – expand the abbreviation (Right/Wrong) 
9.  Post Marketing Surveillance - means (Right/Wrong) 
10.  Name one Pharmacovigilance centre in south India (Right/Wrong) 
 
Results 
 
A total of 100 Interns participated in the study group. 
The age was between 22-28 years. The experience of 
interns was 0-12 months. The participants who 
answered correctly >5 questions were about to finish 
their Internship within 3 months. Overall >90% of the 
participants were not aware of any of these questions. 
The percentage of correct answer for question 5 vs. 10 
was 5-44 vs.90.33 respectively.  
 
Dicussion 
 
This study showed reserved awareness of 
pharmacovigilance among the junior level doctors in a 
tertiary care teaching hospital that >90% of interns did 
not know where and how the ADRs had to be reported. 
So, it is essential to conduct awareness programs to 
improve the ADR reporting is mandatory. In our 
evaluation a prevalence of participants felt that the 
ADR reporting should made compulsory, which again 
corresponding with the results obtained by Qing et al 
and Bateman DN et al study.(6-7) The percentage of 
correct answer for question 6 vs. 10 was 5-33 vs.89.33 
respectively, suggests that the participants were new to 
the terminology Pharmacovigilance. The various 
factors that discourage the medical doctors from a 
spontaneous reporting are due to lack of knowledge  
 
 
 
about the reporting system was well discussed by Patil 
et al [8]. Our study was also gives similar study done 
by Madhavulu et al among clinicians in a tertiary care 
hospital[9]. 
 
Conclusion 
 
Our study strongly recommends a massive need to 
create awareness among the Interns to improve the 
reporting of ADR and awareness about 
Pharmacovigilance. The training sessions must clarify 
the roles of the various healthcare professionals in PV. 
The Pharmacovigilance must be made an essential part 
of the medical education right from 2nd M.B.B.S, in 
order to better patient care. 
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